Colchicine, a recognized anti-inflammatory agent, has demonstrated mechanistic effects in atrial fibrillation in animal studies (47), including inhibition of IL-6 release triggered by IL-1β, attenuation of subsequent atrial fibrosis, and modulation of ion channel gene expression and signaling pathways. Here, IL6 is linked to atrial fibrillation.